Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly [NA]

View source ↗

Summary

A status update for a completed trial evaluating Lactobacillus paracasei PS23 for aging-related muscle loss in the elderly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus paracasei PS23 (Lactobacillus paracasei PS23)

Snippet

Sponsor: Chi-Chang Huang | Conditions: Elderly, Muscle Loss | NA | Status: COMPLETED